Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Riether

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Selective CB2 receptor agonists. Part 2: Structure-activity relationship studies and optimization of proline-based compoundsDoris Riether, Renee Zindell, Lifen Wu, et al.
Journal of Medicinal Chemistry|August 26, 2010
Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimeticsDoris Riether, Christian Harcken, Hossein Razavi, et al.
Journal of Medicinal Chemistry|February 11, 2014
Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effectsChristian Harcken, Doris Riether, Daniel Kuzmich, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidateChristian Harcken, Doris Riether, Pingrong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stabilityDoris Riether, Lifen Wu, Pier F Cirillo, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2014
Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophoreHossein Razavi, Doris Riether, Christian Harcken, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2011
Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: optimization of drug-like properties and target independent parametersRenée Zindell, Edward R Walker, John Scott, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2008
Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivityMonika Ermann, Doris Riether, Edward R Walker, et al.
Journal of Medicinal Chemistry|February 2, 2023
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open ScienceSven Thamm, Marina K Willwacher, Gary E Aspnes, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2009
5-Aminomethylbenzimidazoles as potent ITK antagonistsDoris Riether, Renée Zindell, Jennifer A Kowalski, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Selective CB2 receptor agonists. Part 2: Structure-activity relationship studies and optimization of proline-based compoundsDoris Riether, Renee Zindell, Lifen Wu, et al.
Journal of Medicinal Chemistry|August 26, 2010
Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimeticsDoris Riether, Christian Harcken, Hossein Razavi, et al.
Journal of Medicinal Chemistry|February 11, 2014
Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effectsChristian Harcken, Doris Riether, Daniel Kuzmich, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidateChristian Harcken, Doris Riether, Pingrong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stabilityDoris Riether, Lifen Wu, Pier F Cirillo, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2014
Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophoreHossein Razavi, Doris Riether, Christian Harcken, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2011
Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: optimization of drug-like properties and target independent parametersRenée Zindell, Edward R Walker, John Scott, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2008
Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivityMonika Ermann, Doris Riether, Edward R Walker, et al.
Journal of Medicinal Chemistry|February 2, 2023
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open ScienceSven Thamm, Marina K Willwacher, Gary E Aspnes, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2009
5-Aminomethylbenzimidazoles as potent ITK antagonistsDoris Riether, Renée Zindell, Jennifer A Kowalski, et al.
Pageof 3